(-)-demecolcine increases expression ISO RGD:734292 6480464 Demecolcine results in increased expression of INPP4B mRNA CTD PMID:23649840 1,2-dimethylhydrazine decreases expression ISO RGD:737358 6480464 1, 2-Dimethylhydrazine results in decreased expression of INPP4B mRNA CTD PMID:22206623 1-nitropyrene increases expression ISO RGD:734292 6480464 1-nitropyrene results in increased expression of INPP4B mRNA CTD PMID:19041380 17beta-estradiol multiple interactions ISO RGD:734292 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of INPP4B mRNA more ... CTD PMID:21795739 more ... 17beta-estradiol increases expression ISO RGD:734292 6480464 Estradiol results in increased expression of INPP4B mRNA CTD PMID:21795739 , PMID:23019147 17beta-estradiol decreases expression ISO RGD:734292 6480464 Estradiol results in decreased expression of INPP4B mRNA CTD PMID:24758408 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:734292 6480464 Dihydrotestosterone results in increased expression of INPP4B mRNA CTD PMID:29581250 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:734292 6480464 Tetrachlorodibenzodioxin results in decreased expression of INPP4B mRNA CTD PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of INPP4B mRNA CTD PMID:32109520 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of INPP4B mRNA CTD PMID:22298810 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of INPP4B mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of INPP4B mRNA CTD PMID:21346803 2-hydroxypropanoic acid decreases expression ISO RGD:734292 6480464 Lactic Acid results in decreased expression of INPP4B mRNA CTD PMID:30851411 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:737358 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of INPP4B mRNA CTD PMID:26251327 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of INPP4B mRNA CTD PMID:24780913 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of INPP4B mRNA CTD PMID:30047161 aflatoxin B1 decreases methylation ISO RGD:734292 6480464 Aflatoxin B1 results in decreased methylation of INPP4B gene CTD PMID:27153756 all-trans-retinoic acid increases expression ISO RGD:734292 6480464 Tretinoin results in increased expression of INPP4B mRNA CTD PMID:23830798 amitrole increases expression EXP 6480464 Amitrole results in increased expression of INPP4B mRNA CTD PMID:30047161 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of INPP4B mRNA CTD PMID:16483693 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of INPP4B mRNA CTD PMID:30779732 aristolochic acid A decreases expression ISO RGD:734292 6480464 aristolochic acid I results in decreased expression of INPP4B mRNA CTD PMID:33212167 arsane multiple interactions ISO RGD:734292 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of INPP4B mRNA CTD PMID:32525701 arsane affects methylation ISO RGD:734292 6480464 Arsenic affects the methylation of INPP4B gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:734292 6480464 Arsenic affects the methylation of INPP4B gene CTD PMID:25304211 arsenic atom multiple interactions ISO RGD:734292 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of INPP4B mRNA CTD PMID:32525701 atrazine increases expression ISO RGD:734292 6480464 Atrazine results in increased expression of INPP4B mRNA CTD PMID:22378314 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of INPP4B gene CTD PMID:28931070 benzene decreases expression ISO RGD:734292 6480464 Benzene results in decreased expression of INPP4B mRNA CTD PMID:19162166 benzo[a]pyrene decreases expression ISO RGD:737358 6480464 Benzo(a)pyrene results in decreased expression of INPP4B mRNA CTD PMID:21569818 benzo[a]pyrene decreases methylation ISO RGD:734292 6480464 Benzo(a)pyrene results in decreased methylation of INPP4B promoter CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:734292 6480464 Benzo(a)pyrene affects the methylation of INPP4B 5' UTR CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:734292 6480464 Benzo(a)pyrene results in increased expression of INPP4B mRNA CTD PMID:22316170 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:734292 6480464 7 more ... CTD PMID:20382639 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of INPP4B mRNA CTD PMID:25181051 , PMID:34947998 bisphenol A increases methylation ISO RGD:734292 6480464 bisphenol A results in increased methylation of INPP4B gene CTD PMID:31601247 bisphenol A increases expression ISO RGD:734292 6480464 bisphenol A results in increased expression of INPP4B mRNA CTD PMID:29275510 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of INPP4B gene CTD PMID:28505145 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of INPP4B mRNA CTD PMID:30816183 , PMID:32528016 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of INPP4B mRNA CTD PMID:32479839 butanal decreases expression ISO RGD:734292 6480464 butyraldehyde results in decreased expression of INPP4B mRNA CTD PMID:26079696 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of INPP4B mRNA CTD PMID:19167457 calcitriol increases expression ISO RGD:734292 6480464 Calcitriol results in increased expression of INPP4B mRNA CTD PMID:16002434 , PMID:26485663 carbon nanotube decreases expression ISO RGD:737358 6480464 Nanotubes more ... CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:734292 6480464 CGP 52608 promotes the reaction [RORA protein binds to INPP4B gene] CTD PMID:28238834 cisplatin decreases expression ISO RGD:734292 6480464 Cisplatin results in decreased expression of INPP4B mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:734292 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of INPP4B mRNA CTD PMID:27392435 copper atom multiple interactions ISO RGD:734292 6480464 [NSC 689534 binds to Copper] which results in increased expression of INPP4B mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:734292 6480464 [NSC 689534 binds to Copper] which results in increased expression of INPP4B mRNA CTD PMID:20971185 coumestrol decreases expression ISO RGD:734292 6480464 Coumestrol results in decreased expression of INPP4B mRNA CTD PMID:19167446 crocidolite asbestos increases expression ISO RGD:734292 6480464 Asbestos, Crocidolite results in increased expression of INPP4B mRNA CTD PMID:25351596 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of INPP4B mRNA CTD PMID:26577399 cyclosporin A increases expression ISO RGD:734292 6480464 Cyclosporine results in increased expression of INPP4B mRNA CTD PMID:20106945 daunorubicin affects response to substance ISO RGD:734292 6480464 INPP4B affects the susceptibility to Daunorubicin CTD PMID:17545624 diquat decreases expression ISO RGD:737358 6480464 Diquat results in decreased expression of INPP4B mRNA CTD PMID:36851058 dorsomorphin multiple interactions ISO RGD:734292 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:734292 6480464 Doxorubicin results in decreased expression of INPP4B mRNA CTD PMID:29803840 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of INPP4B mRNA CTD PMID:29391264 folpet decreases expression ISO RGD:737358 6480464 folpet results in decreased expression of INPP4B mRNA CTD PMID:31558096 formaldehyde increases expression ISO RGD:734292 6480464 Formaldehyde results in increased expression of INPP4B mRNA CTD PMID:27664576 genistein decreases expression ISO RGD:734292 6480464 Genistein results in decreased expression of INPP4B mRNA CTD PMID:15378649 hydroquinone increases expression ISO RGD:734292 6480464 hydroquinone results in increased expression of INPP4B mRNA CTD PMID:31256213 hydroquinone O-beta-D-glucopyranoside increases expression ISO RGD:734292 6480464 Arbutin results in increased expression of INPP4B mRNA CTD PMID:17103032 isotretinoin decreases expression ISO RGD:734292 6480464 Isotretinoin results in decreased expression of INPP4B mRNA CTD PMID:20436886 maneb multiple interactions ISO RGD:737358 6480464 [Maneb co-treated with Paraquat] results in decreased expression of INPP4B mRNA CTD PMID:36117858 methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of INPP4B gene CTD PMID:35440735 methylparaben decreases expression ISO RGD:734292 6480464 methylparaben results in decreased expression of INPP4B mRNA CTD PMID:31745603 methylseleninic acid affects expression ISO RGD:734292 6480464 methylselenic acid affects the expression of INPP4B mRNA CTD PMID:14617803 O-methyleugenol decreases expression ISO RGD:734292 6480464 methyleugenol results in decreased expression of INPP4B mRNA CTD PMID:32234424 panobinostat multiple interactions ISO RGD:734292 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INPP4B mRNA CTD PMID:27188386 paraquat increases expression EXP 6480464 Paraquat results in increased expression of INPP4B mRNA CTD PMID:18198484 paraquat multiple interactions ISO RGD:737358 6480464 [Maneb co-treated with Paraquat] results in decreased expression of INPP4B mRNA CTD PMID:36117858 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of INPP4B mRNA CTD PMID:28511854 phenylmercury acetate increases expression ISO RGD:734292 6480464 Phenylmercuric Acetate results in increased expression of INPP4B mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:734292 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INPP4B mRNA CTD PMID:27188386 potassium chromate decreases expression ISO RGD:734292 6480464 potassium chromate(VI) results in decreased expression of INPP4B mRNA CTD PMID:22714537 progesterone multiple interactions ISO RGD:734292 6480464 Progesterone inhibits the reaction [Estradiol results in increased expression of INPP4B mRNA] CTD PMID:21795739 progesterone decreases expression ISO RGD:734292 6480464 Progesterone results in decreased expression of INPP4B mRNA CTD PMID:20864642 rac-lactic acid decreases expression ISO RGD:734292 6480464 Lactic Acid results in decreased expression of INPP4B mRNA CTD PMID:30851411 raloxifene affects expression ISO RGD:734292 6480464 Raloxifene Hydrochloride affects the expression of INPP4B mRNA CTD PMID:14699072 resveratrol decreases expression ISO RGD:734292 6480464 resveratrol results in decreased expression of INPP4B mRNA CTD PMID:18586690 , PMID:19167446 rotenone decreases expression ISO RGD:734292 6480464 Rotenone results in decreased expression of INPP4B mRNA CTD PMID:33512557 SB 431542 multiple interactions ISO RGD:734292 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases methylation ISO RGD:734292 6480464 Silicon Dioxide results in increased methylation of INPP4B gene CTD PMID:34973136 sodium arsenate multiple interactions ISO RGD:734292 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of INPP4B mRNA CTD PMID:32525701 sodium arsenite increases expression ISO RGD:734292 6480464 sodium arsenite results in increased expression of INPP4B mRNA CTD PMID:29301061 sodium arsenite decreases expression ISO RGD:734292 6480464 sodium arsenite results in decreased expression of INPP4B mRNA CTD PMID:34032870 sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of INPP4B mRNA CTD PMID:30047161 testosterone decreases expression ISO RGD:734292 6480464 Testosterone results in decreased expression of INPP4B mRNA CTD PMID:33359661 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of INPP4B mRNA CTD PMID:31150632 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of INPP4B mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:734292 6480464 trichostatin A results in increased expression of INPP4B mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:734292 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INPP4B mRNA CTD PMID:27188386 triptonide increases expression ISO RGD:737358 6480464 triptonide results in increased expression of INPP4B mRNA CTD PMID:33045310 valproic acid decreases methylation ISO RGD:734292 6480464 Valproic Acid results in decreased methylation of INPP4B gene CTD PMID:29154799 valproic acid multiple interactions ISO RGD:734292 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INPP4B mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:734292 6480464 Valproic Acid results in increased expression of INPP4B mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:734292 6480464 Valproic Acid affects the expression of INPP4B mRNA CTD PMID:25979313 vincristine increases expression ISO RGD:734292 6480464 Vincristine results in increased expression of INPP4B mRNA CTD PMID:23649840 vorinostat multiple interactions ISO RGD:734292 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INPP4B mRNA CTD PMID:27188386 zinc atom multiple interactions ISO RGD:734292 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of INPP4B mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RGD:734292 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of INPP4B mRNA CTD PMID:18593933
